<!DOCTYPE html>
<html lang="en-GB">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Insertion Procedure - Impella ICU Guideline</title>
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        :root {
            --nhs-blue: #005EB8; --nhs-dark-blue: #003087; --nhs-white: #FFFFFF;
            --nhs-black: #212B32; --nhs-grey: #4C6272; --nhs-light-grey: #AEB7BD;
            --nhs-pale-grey: #F0F4F5; --nhs-pale-blue: #E8EDEE; --warning-yellow: #FFB81C;
        }
        body { font-family: "Frutiger W01", Arial, sans-serif; line-height: 1.6; color: var(--nhs-black); background-color: var(--nhs-pale-grey); }
        .header { background: linear-gradient(135deg, var(--nhs-dark-blue) 0%, var(--nhs-blue) 100%); color: var(--nhs-white); padding: 1.5rem 2rem; box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1); }
        .header-content { max-width: 1200px; margin: 0 auto; display: flex; justify-content: space-between; align-items: center; }
        .header h1 { font-size: 1.5rem; font-weight: 600; }
        .breadcrumb { background: white; padding: 1rem 2rem; box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1); }
        .breadcrumb-content { max-width: 1200px; margin: 0 auto; display: flex; align-items: center; gap: 0.5rem; font-size: 0.9rem; }
        .breadcrumb a { color: var(--nhs-blue); text-decoration: none; }
        .breadcrumb a:hover { text-decoration: underline; }
        .breadcrumb span { color: var(--nhs-grey); }
        .container { max-width: 1200px; margin: 2rem auto; padding: 0 2rem; }
        .content-card { background: white; padding: 2.5rem; border-radius: 8px; box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1); margin-bottom: 2rem; }
        .section-header { color: var(--nhs-blue); font-size: 2rem; margin-bottom: 0.5rem; padding-bottom: 1rem; border-bottom: 3px solid var(--nhs-blue); }
        .section-meta { color: var(--nhs-grey); font-size: 0.9rem; margin-bottom: 2rem; }
        h2 { color: var(--nhs-blue); font-size: 1.5rem; margin: 2rem 0 1rem 0; padding-bottom: 0.5rem; border-bottom: 2px solid var(--nhs-pale-blue); }
        h3 { color: var(--nhs-dark-blue); font-size: 1.25rem; margin: 1.5rem 0 1rem 0; }
        p { margin-bottom: 1rem; }
        ol { margin: 1rem 0 1rem 1rem; counter-reset: item; }
        ol > li { margin-bottom: 1.5rem; display: block; padding-left: 2rem; position: relative; }
        ol > li:before { content: counter(item) ". "; counter-increment: item; font-weight: 700; color: var(--nhs-blue); font-size: 1.2rem; position: absolute; left: 0; }
        ul { margin: 0.5rem 0 0.5rem 2rem; }
        ul li { margin-bottom: 0.5rem; }
        strong { color: var(--nhs-dark-blue); }
        .alert-warning { background: #FFF7E5; border-left: 4px solid var(--warning-yellow); padding: 1.5rem; margin: 1.5rem 0; border-radius: 4px; }
        .figure { margin: 2rem 0; text-align: center; }
        .figure img { max-width: 100%; height: auto; border: 1px solid var(--nhs-light-grey); border-radius: 4px; box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1); }
        .figure-caption { margin-top: 0.75rem; font-style: italic; color: var(--nhs-grey); font-size: 0.95rem; }
        .navigation-buttons { display: flex; justify-content: space-between; margin-top: 3rem; padding-top: 2rem; border-top: 2px solid var(--nhs-pale-grey); }
        .nav-button { display: inline-flex; align-items: center; gap: 0.5rem; padding: 0.75rem 1.5rem; background: var(--nhs-blue); color: white; text-decoration: none; border-radius: 4px; font-weight: 600; transition: background 0.3s ease; }
        .nav-button:hover { background: var(--nhs-dark-blue); }
        .nav-button.secondary { background: var(--nhs-grey); }
        .nav-button.secondary:hover { background: var(--nhs-dark-blue); }
        footer { background: var(--nhs-dark-blue); color: white; text-align: center; padding: 1.5rem; margin-top: 3rem; }
        footer p { margin-bottom: 0.25rem; opacity: 0.9; font-size: 0.9rem; }
        @media (max-width: 768px) {
            .header-content { flex-direction: column; text-align: center; gap: 1rem; }
            .container { padding: 0 1rem; }
            .content-card { padding: 1.5rem; }
            .navigation-buttons { flex-direction: column; gap: 1rem; }
        }
    </style>
</head>
<body>
    <header class="header">
        <div class="header-content">
            <h1>Impella CP with SmartAssist - ICU Guideline</h1>
            <a href="../../index.html" class="nav-button secondary">← Back to Contents</a>
        </div>
    </header>

    <nav class="breadcrumb">
        <div class="breadcrumb-content">
            <a href="../../index.html">Home</a>
            <span>›</span>
            <span>Section 3</span>
            <span>›</span>
            <span>Insertion Procedure</span>
        </div>
    </nav>

    <div class="container">
        <div class="content-card">
            <h1 class="section-header">Section 3: Insertion Procedure</h1>
            <div class="section-meta">Version 3.2 | March 2025 – December 2026</div>

            <div class="alert-warning">
                <p><strong>⚠️ Important:</strong> All insertions of Impella catheters are to be performed in the cardiac catheter lab or cardiac theatres by a trained consultant Interventional Cardiologist or Cardiac Surgeon.</p>
            </div>

            <h2>Pre-Insertion Considerations</h2>

            <ol>
                <li>All patients planned electively for an Impella (either as an inpatient or an outpatient) should be assessed for a history of peripheral vascular disease (PVD). If there is a history of PVD or a history of claudication, CT aortic/iliac/femoral angiogram should be acquired prior to planned device insertion to assess patency of peripheral vessels. This will then allow planning for the appropriate approach to the insertion which may be femoral, subclavian or axillary - the latter two via either a percutaneous or surgical approach.</li>

                <li>All patients should have the following blood tests prior to the procedure: full blood count, coagulation screen, renal biochemistry and two sets of group and save.</li>

                <li>Baseline echo to ensure there is no significant aortic valve disease or LV thrombus.</li>

                <li>If the patient is not a current inpatient, the patient should be admitted to a cardiac ward/CCU the day before the procedure.</li>

                <li>Strong consideration needs to be given to having anaesthetic support planned and available from the start of the case, given the high probability of deteriorating cardiogenic shock. Anaesthesia support should be requested via:
                    <ul>
                        <li><strong>Elective / Semi-Elective case:</strong> Cardiac Anaesthesia group, via the CICU consultant</li>
                        <li><strong>Emergency case:</strong> General Anaesthesia group (Bleep 3036), or Cardiogenic Shock Team (CST) activation via 2222 if the patient meets the calling criteria</li>
                    </ul>
                </li>

                <li>If the Impella is explanted successfully at the end of the procedure and there are no signs of shock (see Appendix 1 – BHI Ventricular Support Algorithm) the patient should be nursed on CCU, utilising the high-risk bundle.</li>

                <li>If the Impella is being inserted for cardiogenic shock, or it is likely to remain in situ after a high-risk PCI, GICU (A600) should be given as much notice as possible, as this is where the patient will be sent post procedure. <strong>GICU Consultant referral phone – 27139.</strong></li>

                <li>Place a urinary catheter prior to Impella insertion if the device is likely to remain in situ.</li>
            </ol>

            <h2>Insertion Procedure</h2>

            <ol>
                <li><strong>Femoral artery access is the standard.</strong> Ultrasound guidance is essential.</li>

                <li>Femoral angiogram required prior to insertion to ensure no significant PVD that would preclude insertion of a large sheath.</li>

                <li><strong>Catheter preparation:</strong> See separate catheter preparation page for detailed steps and Figure 6.</li>

                <li>Insert 14Fr sheath via Seldinger technique (may require pre-dilation with smaller dilators provided) and administer heparin bolus before Impella device is inserted (<strong>70 units per kg, to achieve an activated clotting time (ACT) of >250 seconds</strong> at the time of dilator removal and Impella insertion). Note if device being used at the time of PCI only, a vascular closure device should be deployed prior to Impella insertion. If there is a likelihood of the device remaining in post procedure no closure device should be used.</li>

                <li>Remove stiff 0.035 guide wire used to insert sheath. Insert an AL-1 or multi-purpose catheter or pigtail catheter over a standard 0.035 guide wire into the LV using fluoroscopy, remove the guide wire and insert the 0.018 guide wire into the LV via the catheter. Remove diagnostic catheter.</li>

                <li>Load Impella catheter on the placement guidewire through the lumen in the temporary red plastic tube as indicated. Once loaded, advance into the LV using fluoroscopy. In emergent situations, the Impella can be inserted directly into the LV, without the need for a 0.018 guide wire.</li>

                <li><strong>Ensure the pigtail and inlet are in the LV, and the outlet in the aorta.</strong></li>

                <li>Start Impella after guidewire removed. <strong>AUTO will be the starting setting.</strong></li>

                <li>Ensure any slack is removed from the catheter.</li>

                <li>Check motor current and pressure signals are adequate. Document position after insertion both at catheter shaft and using fluoroscopy. A well-positioned Impella catheter is one that is stable and does not migrate, produces unobstructed flow, the outflow is well above aortic valve and the device free from the anterior leaflet of the mitral valve.</li>

                <li>To reduce the risk of ischaemic limb complications, the peel-away 14F sheath can be removed and swapped to the repositioning sheath. The decision about exchanging the 14F sheath to the repositioning sheath is at the discretion of the operator. We would advise keeping the 14F sheath in if the device is only planned to be in for the procedure (and a vascular closure device is used) or for a short period afterwards (or if there may be a need to upgrade to ECMO), given the risks of bleeding with the repositioning sheath and need for vessel access for the closure devices.</li>

                <li>If a decision is made to swap to repositioning sheath this can be done as follows:
                    <ul>
                        <li>Place pressure above sheath on femoral artery</li>
                        <li>Remove 14F sheath completely out of the groin before peeling</li>
                        <li>Peel away the 14F sheath and advance the tapered repositioning sheath (which comes preloaded on the catheter)</li>
                        <li>Attach and securely tighten Tuohy Borst adapter, suture wings to skin</li>
                    </ul>
                </li>

                <li>After procedure, secure catheter with sutures and tegaderm and document the position of the device at the sheath entry point. To reduce bleeding from the Impella sheath entry point when using the repositioning sheath, gauze can be placed underneath the repositioning sheath to apply a larger angle from the skin. A femstop device can also be applied with light pressure over the exit site.</li>

                <li>A screening echocardiogram should be performed prior to leaving the cath lab to document device position in the LV.</li>

                <li>If there is ongoing haemodynamic instability and/or a need for prolonged support, the insertion of an arterial line +/- CVC should be performed prior to transfer to ICU. If inserting a CVC, this would ideally be in the left internal jugular vein, to avoid vessels needed for potential PAC and ECMO cannula insertion.</li>

                <li>Pre-transfer to ICU, the purge fluid should be changed to the bicarbonate solution, if the heparin solution has been used in the cath lab (500mls of dextrose 5% with 12.5mls of 8.4% sodium bicarbonate injected into it).</li>
            </ol>

            <p><strong>For further education on insertion, visit the Abiomed website:</strong><br>
            <a href="https://www.heartrecovery.com/education/education-library/qsv-impella-cp-with-smartassist-setup-procedure" target="_blank">https://www.heartrecovery.com/education/education-library/qsv-impella-cp-with-smartassist-setup-procedure</a></p>

        </div>

        <div class="navigation-buttons">
            <a href="../../index.html" class="nav-button">← Back to Contents</a>
            <a href="../../index.html" class="nav-button">Back to Contents →</a>
        </div>
    </div>

    <footer>
        <p><strong>Version 3.2</strong> | Valid: March 2025 – December 2026</p>
        <p>University Hospitals Bristol and Weston NHS Foundation Trust</p>
    </footer>
</body>
</html>
